Ethyl 1,2-dihydro-1,6-dimethyl/6-methyl-2-oxopyrimidine-5-carboxylates react with C-nucleophiles as well as anion of enantiopure chiral auxiliary (1R,2S,5R)-(-)-methyl (S)-p-toluenesulfinate to afford C-4 substituted and enantiopure congeners of medicinally potent Biginelli dihydropyrimidinones. The calcium channel blocking activity of some of the compounds was evaluated and compared with nifedipine for their ability to relax a membrane depolarization induced contraction.
Ethyl 1,2-dihydro-1,6-dimethyl/6-methyl-2-oxopyrimidine-5-carboxylates react with C-nucleophiles as well as anion of enantiopure chiral auxiliary (1Rn class="Chemical">,2S,5R)-(-)-methyl (S)-p-toluenesulfinate to afford C-4 substituted and enantiopure congeners of medicinally potent Biginelli dihydropyrimidinones. The calcium channel blocking activity of some of the compounds was evaluated and compared with nifedipine for their ability to relax a membrane depolarization induced contraction.
Authors: G C Rovnyak; S D Kimball; B Beyer; G Cucinotta; J D DiMarco; J Gougoutas; A Hedberg; M Malley; J P McCarthy; R Zhang Journal: J Med Chem Date: 1995-01-06 Impact factor: 7.446
Authors: J C Barrow; P G Nantermet; H G Selnick; K L Glass; K E Rittle; K F Gilbert; T G Steele; C F Homnick; R M Freidinger; R W Ransom; P Kling; D Reiss; T P Broten; T W Schorn; R S Chang; S S O'Malley; T V Olah; J D Ellis; A Barrish; K Kassahun; P Leppert; D Nagarathnam; C Forray Journal: J Med Chem Date: 2000-07-13 Impact factor: 7.446
Authors: Fang Wang; Robert M Wenslow; Thomas M Dowling; Karl T Mueller; Ivan Santos; Jean M Wyvratt Journal: Anal Chem Date: 2003-11-01 Impact factor: 6.986
Authors: Abel Crespo; Abdelaziz El Maatougui; Pierfrancesco Biagini; Jhonny Azuaje; Alberto Coelho; José Brea; María Isabel Loza; María Isabel Cadavid; Xerardo García-Mera; Hugo Gutiérrez-de-Terán; Eddy Sotelo Journal: ACS Med Chem Lett Date: 2013-10-03 Impact factor: 4.345
Authors: Francisco Sánchez-Sancho; Marcos Escolano; Daniel Gaviña; Aurelio G Csáky; María Sánchez-Roselló; Santiago Díaz-Oltra; Carlos Del Pozo Journal: Pharmaceuticals (Basel) Date: 2022-07-30